Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome | MicrobiomeTrials← Back to trialsNCT07894107
Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-03Est. Completion: 2030-02-28
Enrollment target: 3,000 participants Locations- Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
- The First Medical Center, Chinese PLA General Hospital, Beijing, Beijing Municipality, China
- Henan Provincial People's Hospital, Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
- Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China
- The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
- The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
- Huashan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
- Children's Hospital of Fudan University, Shanghai, Shanghai Municipality, China
- West China Hospital, Sichuan University, Chengdu, Sichuan, China
- The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
Unruptured Intracranial AneurysmIntracranial Aneurysm Rupture
This is a single-center, prospective, longitudinal observational cohort study in adults with unruptured intracranial ane…
Beijing, ChinaEst. completion Dec 31, 2037
Moyamoya Disease
Moyamoya disease is a relatively rare chronic cerebrovascular disease, and its exact cause is currently unknown. This di…
Nanjing, ChinaCompleted Jan 31, 2027